Humanoids Operate on Pigs: The End of Expensive Surgical Robots?

What Happened?

A team from the University of California, San Diego (UCSD) achieved a milestone in robotic surgery: a Unitree G1 humanoid robot, teleoperated by surgeons, performed two cholecystectomies (gallbladder removal) on live pigs. The results were published in the journal Nature (DOI: 10.1038/s41586-026-10796-x). Importantly, the robots did not act autonomously; each movement was remotely controlled by an expert surgeon, demonstrating a new form of human-robot collaboration. This experiment, described as the first of its kind, was reported by Ars Technica and Slashdot, and represents a significant advance in democratizing assisted surgery.

Why Is This Important?

The current robotic surgery system is dominated by Intuitive Surgical's da Vinci, which costs between $500,000 and several million dollars, weighs about 800 kg, and requires specialized facilities. In contrast, the Unitree G1, manufactured by Chinese company Unitree, has a base price of $13,500 (version without functional hands), and with enhanced dexterous hands reaches about $67,000. Weighing only 27 kg and standing 1.5 m tall, it is much more accessible for small hospitals, rural clinics, conflict zones, or even space missions. Dr. Shanglei Liu, a surgeon at UCSD, stated: "It's a fraction of the cost and takes up a fraction of the space in an operating room. It's easy to deploy in rural areas, battlefields, and even space." This contrast in cost and size could revolutionize the availability of robotic surgery.

Consequences and Perspectives

While this is a successful preclinical trial, the path to human use requires further safety and efficacy studies. However, the teleoperation approach with generic humanoid robots could democratize assisted surgery, narrowing the gap between high-tech centers and underserved areas. Moreover, being a general-purpose robot, it could be reused for other tasks outside the operating room, maximizing the investment. Compared to earlier events, such as the introduction of the da Vinci system in 2000, which cost millions and required specialized infrastructure, the Unitree G1 represents a paradigm shift toward lighter, cheaper, and more versatile robots. Nevertheless, challenges remain: precision of movements, connection latency, need for advanced haptic interfaces, and regulatory certification. The experiment used a robot with enhanced dexterous hands, costing close to $67,000, still far below the da Vinci.

What Readers Should Know

• This is not autonomous surgery: the surgeon controls every movement.
• The technology is promising but still in the preclinical phase (animals).
• The Unitree G1 robot is Chinese, adding geopolitical and supply chain considerations.
• Cost savings could allow more hospitals to access robotic surgery.

The study lays the groundwork for a future where robotic surgery is not a privilege of the few. As Dr. Liu notes, the goal is to bring the surgeon's expertise anywhere in the world. In terms of market impact, the entry of generic humanoid robots could pressure manufacturers like Intuitive Surgical to reduce costs or innovate with more compact systems. For users (hospitals and patients), this potentially means less invasive and more accessible surgeries in remote regions. However, network latency remains an issue: any delay could compromise safety. Previous studies have shown that telesurgery with specialized robots has acceptable latency below 300 ms, but the Unitree G1 is not optimized for this. Additionally, regulatory certification (FDA, CE) for human use could take years. Despite these challenges, the experiment represents an important step toward low-cost, high-availability robotic surgery.